These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 3652557

  • 1. The hyperornithinemia, hyperammonemia, homocitrullinuria syndrome: an ornithine transport defect remediable with ornithine supplements.
    Gordon BA, Gatfield DP, Haust MD.
    Clin Invest Med; 1987 Jul; 10(4):329-36. PubMed ID: 3652557
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome: low creatine excretion and effect of citrulline, arginine, or ornithine supplement.
    Dionisi Vici C, Bachmann C, Gambarara M, Colombo JP, Sabetta G.
    Pediatr Res; 1987 Sep; 22(3):364-7. PubMed ID: 3116497
    [Abstract] [Full Text] [Related]

  • 7. Hyperornithinemia, hyperammonemia, and homocitrullinuria syndrome with evidence of mitochondrial dysfunction due to a novel SLC25A15 (ORNT1) gene mutation in a Palestinian family.
    Korman SH, Kanazawa N, Abu-Libdeh B, Gutman A, Tsujino S.
    J Neurol Sci; 2004 Mar 15; 218(1-2):53-8. PubMed ID: 14759633
    [Abstract] [Full Text] [Related]

  • 8. [Hyperornithinemia, hyperammonemia and homocitrullinuria syndrome in a family].
    Koike R, Fujimori K, Yuasa T, Miyatake T.
    Rinsho Shinkeigaku; 1987 Apr 15; 27(4):465-71. PubMed ID: 3621746
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Clinical, biochemical and ultrastructural study on the pathogenesis of hyperornithinemia-hyperammonemia-homocitrullinuria syndrome.
    Nakajima M, Ishii S, Mito T, Takeshita K, Takashima S, Takakura H, Inoue I, Saheki T, Akiyoshi H, Ichihara K.
    Brain Dev; 1988 Apr 15; 10(3):181-5. PubMed ID: 3407856
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of ornithine metabolism in hyperornithinaemia-hyperammonaemia-homocitrullinuria syndrome, lysinuric protein intolerance and gyrate atrophy fibroblasts.
    Botschner J, Smith DW, Simell O, Scriver CR.
    J Inherit Metab Dis; 1989 Apr 15; 12(1):33-40. PubMed ID: 2501580
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Hyperornithinemia, hyperammonemia, and homocitrullinuria. A new disorder of amino acid metabolism associated with myoclonic seizures and mental retardation.
    Shih VE, Efron ML, Moser HW.
    Am J Dis Child; 1969 Jan 15; 117(1):83-92. PubMed ID: 5782534
    [No Abstract] [Full Text] [Related]

  • 18. Ciliated cultured dermal fibroblasts in a patient with hyperornithinemia, hyperammonemia and homocitrullinuria (HHH) syndrome.
    Haust MD.
    Pathol Res Pract; 1995 Oct 15; 191(10):1062-5. PubMed ID: 8838382
    [Abstract] [Full Text] [Related]

  • 19. Hyperornithinemia, hyperammonemia, and homocitrullinuria: case report and biochemical study.
    Koike R, Fujimori K, Yuasa T, Miyatake T, Inoue I, Saheki T.
    Neurology; 1987 Nov 15; 37(11):1813-5. PubMed ID: 3670619
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.